Unjha Formulations Limited

₹28.50As of Sun 8 Nov 2026, 12:00 UTC
BSE:531762Healthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR 7.76%
Div yield —
ROE 3.70%
Pharmaceutical Preparations
Beta (5Y) (0.27)
PE TTM 78.08
TSR TTM 18.75%
Mkt cap ₹127.7M
ROIC 4.19%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹36
27.30%
(83.78%)
Hold 9|3|10|11|12
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
0.38
0.39
0.39
0.38
5.65%
10.77%
6.62%
3.76%
Revenue₹M
8.866
9.058
9.341
9.483
6.25%
6.46%
10.54%
12.89%
Peers (US$1.314M)
Cap (US$)
PE
1.397M
21.01x
1.196M
26.75x
Capital
TTM
5Y
10Y
Leveragex
0.843
(0.024)
(0.022)
EBIT/Intx
2.229
0.481
0.444
Own earn%
(26.92)
(21.88)
(15.76)
Sh yield%
15.97
42.66
45.27
Owners
Insiders/Inst%
8.25
52.15
Short interest%
3.00
SBC / revenue%
2.50
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
22
Op margin range%
11–15
$1 testx
—
Incr. ROIC%
23